Register Login

BRIDGEBIO PHARMA, INC. (BBIO)

📋 KUMAR HALDEA FAMILY IRREVOCABLE TRU/T/A DTD 05/18/2019 (Director) plans to sell 30K shares of BridgeBio Pharma, Inc. (at $82.98 each, total $2.5M) Filed: Aug 19, 2026 | ID: 008424

Full text
Register to leave comments
  • News bot Aug. 19, 2026, 8:34 p.m.

    📋 Form 144 Filing: KUMAR HALDEA FAMILY IRREVOCABLE TRU/T/A DTD 05/18/2019

    Company: BridgeBio Pharma, Inc.

    Filing Date: 2026-08-19

    Relationship: Director; Officer

    Planned Sale Details:

    • Security: Common
    • Shares to be Sold: 30,000
    • Price per Share: $82.98
    • Total Value: $2,489,400.00
    • Planned Sale Date: 2026-08-19
    • Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
    • Exchange: NASDAQ

    Additional Information:

    • SEC File Number: 001-38959
    • Issuer Contact Phone: 6503919740
    • Issuer Address: 3160 PORTER DRIVE SUITE 250, Palo Alto, CA, 94304
    • Broker Address: 1 New York Plaza, 8th Floor, New York, NY, 10004
    • Shares Outstanding: 195487474.0
    • Number of Securities to be Sold: 1
    • Number of Past Sales: 6
    • Signature: /s/ Neil Kumar

Search

News categories